SolasCure

Cambridge, United Kingdom · Founded 2017 · Privately Held (backing)

Developer of hydrogel designed to treat patients with chronic wounds. SolasCure is based in Cambridge, United Kingdom and was founded in 2017. Its last reported valuation was $57 million in Jan 2021. It has raised $34.2 million.

Last reported valuation
$57.0M
Oct 2026
Priced at
—
Total raised
$34.2M
Last round
—

Who backs SolasCure?

17 investors
InvestorType
Innovate UKOther
European Innovation CouncilVenture capital
Texas Medical CenterVenture capital
SyndicateRoomVenture capital
Development Bank of WalesVenture capital
Meltwind Advisory—
Jonathan Milner—
Khattar HoldingsFamily office
BRAIN Biotech—
Bionova Capital—
+ 7 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

SolasCure investors

17 investors are on record for SolasCure, including Innovate UK, European Innovation Council, Texas Medical Center and SyndicateRoom. By type, the record holds 4 venture capital firms and 1 family office.

Free account
More of SolasCure with a free account
  • ·The complete investor list: 17 names
  • ·Watch SolasCure: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 17 firms already write checks for companies like SolasCure. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View